26.02.2013
- The U.S. Food and Drug Administration said on Tuesday it has stopped all pediatric clinical trials of Amgen's Sensipar after the death of a 14-year-old patient taking part in a...
07.02.2013
- Amgen said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of the industry's...
07.02.2013
- Amgen, the world's largest biotechnology company, on Thursday raised its 2013 earnings forecast to account for a Puerto Rico excise tax credit due to federal settlements for prior...
24.01.2013
- Amgen on Wednesday projected revenue for 2013 that exceeds Wall Street estimates and said it was on track to deliver on its 2015 forecasts well ahead of schedule. The world's...
17.01.2013
- Amgen, the world's largest biotechnology company, announced on Wednesday plans to build a new manufacturing plant in Singapore. Thousand Oaks, California-based Amgen said it plans...
16.01.2013
- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that it has signed a non-exclusive license agreement with Amgen for...
09.01.2013
- Amgen, the world's largest biotechnology company, on Tuesday lowered its outlook for 2012 earnings per share by 10 cents, citing a delay in the impact of a U.S. tax credit for...
20.12.2012
- A federal judge on Wednesday approved a $762 million payment from Amgen, the final step to resolve nearly a dozen criminal and civil cases stemming from the sale of its once...
